Circulation. 2008;117:2311-2312
doi: 10.1161/CIRCULATIONAHA.108.770594
(Circulation. 2008;117:2311-2312.)
© 2008 American Heart Association, Inc.
Adult Congenital Heart Disease
Toward Prospective Risk Assessment of a Multisystemic Condition
Paul Khairy, MD, PhD;
Michael J. Landzberg, MD
From the Adult Congenital Heart Center, Montreal Heart Institute, Montreal, Canada (P.K.), and Boston Adult Congenital Heart (BACH) Service, Childrens Hospital Boston, Boston, Mass (P.K., M.J.L.).
Reprint requests to Dr Paul Khairy, Adult Congenital Heart Center, Montreal Heart Institute, 5000 Bélanger St, Montreal, Quebec, Canada, H1T 1C8. E-mail paul.khairy@umontreal.ca
Key Words: Editorials heart defects, congenital kidney prognosis
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
It has long been recognized that manifestations of congenital
heart disease extend beyond the cardiovascular system. The extracardiac
ramifications of congenital heart disease are multifaceted and
bidirectional. The intricate interplay between congenital heart
physiology, bi- or univentricular heart function, early and/or
ongoing cyanosis, surgical and residual sequelae, and multisystemic
effects are increasingly appreciated. Examples include the well-characterized
neurological, hematologic, respiratory, skeletal, and hepatic
consequences of cyanosis
1; thromboembolic complications in surgically
palliated univentricular hearts
2; and dysregulation of the autonomic
nervous system in various forms of congenital heart disease.
3
Article p 2320
In the present issue of Circulation, Dimopoulos and associates4 provide original and important insights regarding the relationship between congenital heart disease and impaired renal function. They examine the prevalence of renal dysfunction across a wide-spectrum of adult congenital heart defects and explore implications on overall death rates.
 |
Methodological Considerations
|
|---|
Heterogeneity of the Study Population
A general and common challenge in congenital heart disease research
that encompasses a broad spectrum of cardiac disorders is the
complexity and marked heterogeneity of the study population.
From a methodological perspective, there is often a trade-off
between heterogeneity of the patient population and the precision
of a given statistical inference. When the objective is to provide
a global perspective on a novel association, such as renal dysfunction
and death in adults with congenital heart disease, however,
heterogeneity of the patient population may be advantageous.
The nonrestrictive inclusion criteria enhance generalizability
of the findings to a broad target population. Although the reported
overall 9.3% prevalence of moderate to severe renal
. . . [Full Text of this Article]